A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits

Citation
Jc. Rymer et al., A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits, CLIN CHEM, 45(6), 1999, pp. 869-881
Citations number
34
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICAL CHEMISTRY
ISSN journal
00099147 → ACNP
Volume
45
Issue
6
Year of publication
1999
Part
1
Pages
869 - 881
Database
ISI
SICI code
0009-9147(199906)45:6<869:ANAFCB>2.0.ZU;2-5
Abstract
Background: Principal component analysis (PCA) is a powerful mathematical m ethod able to analyze data sets containing a large number of variables. To our knowledge, this method is applied here for the first time in the field of medical laboratory analysis. Methods: PCA was used to evaluate the results of a blind comparative study of 21 carcinoembryonic antigen (CEA) reagent kits used to determine CEA con centration in a panel of sera from 80 patients. Results: The mathematical technique first eliminated the variations attribu table to the use of different calibrators. The PCA representation then gave a global view of the dispersion of the kits and allowed the identification of a main homogeneous group and of some discrepant kits. Conclusions: PCA applied to the in vitro diagnostic reagent field could con tribute to the standardization process and improve the quality of medical l aboratory analyses. A standardization method using a panel of patient sera is proposed. (C) 1999 American Association for Clinical Chemistry.